Cerebral Embolectomy in patients with acute stroke
Conditions
Brief summary
Proportion of patients with a mRS 0 to 1 at 90 days.
Detailed description
•Proportion of patients with abnormal microvascular hypoperfusion on CT Perfusion at 36±24h post MT. • Volume of hypoperfusion on brain CTP at 36h±24h post MT •Infarct Expansion Ratio (IER): Final infarct to initial ischemic tissue volumes on brain NCCT at 36±24h post MT. •Barthel Scale score of 95 to 100, at day 90. •Quality of life measured with the EuroQol Group 5-Dimension Self-Report Questionnaire (EQ-5D-5L) at 90 days. •The shift analysis of the modified Rankin Scale (mRS), at day 90.
Interventions
Sponsors
Foundation Clinic For Biomedical Research
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with a mRS 0 to 1 at 90 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| •Proportion of patients with abnormal microvascular hypoperfusion on CT Perfusion at 36±24h post MT. • Volume of hypoperfusion on brain CTP at 36h±24h post MT •Infarct Expansion Ratio (IER): Final infarct to initial ischemic tissue volumes on brain NCCT at 36±24h post MT. •Barthel Scale score of 95 to 100, at day 90. •Quality of life measured with the EuroQol Group 5-Dimension Self-Report Questionnaire (EQ-5D-5L) at 90 days. •The shift analysis of the modified Rankin Scale (mRS), at day 90. | — |
Countries
Spain
Outcome results
None listed